Report Detail
COVID-19 Impact on Global Natural Killer Cell Therapies Market Insights, Forecast to 2026
- RnM4015479 |
- 08 June, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Natural Killer Cell Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer Cell Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Natural Killer Cell Therapies market is segmented into
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application, the Natural Killer Cell Therapies market is segmented into
Cancer
Gastrointestinal Diseases
Others
Regional and Country-level Analysis
The Natural Killer Cell Therapies market is analysed and market size information is provided by regions (countries).
The key regions covered in the Natural Killer Cell Therapies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Natural Killer Cell Therapies Market Share Analysis
Natural Killer Cell Therapies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Natural Killer Cell Therapies business, the date to enter into the Natural Killer Cell Therapies market, Natural Killer Cell Therapies product introduction, recent developments, etc.
The major vendors covered:
Nektar Therapeutics
Innate
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
1 Study Coverage
- 1.1 Natural Killer Cell Therapies Product Introduction
- 1.2 Market Segments
- 1.3 Key Natural Killer Cell Therapies Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Natural Killer Cell Therapies Market Size Growth Rate by Type
- 1.4.2 NK Cell Therapies
- 1.4.3 NK Cell Directed Antibodies
- 1.5 Market by Application
- 1.5.1 Global Natural Killer Cell Therapies Market Size Growth Rate by Application
- 1.5.2 Cancer
- 1.5.3 Gastrointestinal Diseases
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Natural Killer Cell Therapies Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Natural Killer Cell Therapies Industry
- 1.6.1.1 Natural Killer Cell Therapies Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Natural Killer Cell Therapies Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Natural Killer Cell Therapies Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Natural Killer Cell Therapies Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Natural Killer Cell Therapies Market Size Estimates and Forecasts
- 2.1.1 Global Natural Killer Cell Therapies Revenue 2015-2026
- 2.1.2 Global Natural Killer Cell Therapies Sales 2015-2026
- 2.2 Natural Killer Cell Therapies Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Natural Killer Cell Therapies Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Natural Killer Cell Therapies Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Natural Killer Cell Therapies Competitor Landscape by Players
- 3.1 Natural Killer Cell Therapies Sales by Manufacturers
- 3.1.1 Natural Killer Cell Therapies Sales by Manufacturers (2015-2020)
- 3.1.2 Natural Killer Cell Therapies Sales Market Share by Manufacturers (2015-2020)
- 3.2 Natural Killer Cell Therapies Revenue by Manufacturers
- 3.2.1 Natural Killer Cell Therapies Revenue by Manufacturers (2015-2020)
- 3.2.2 Natural Killer Cell Therapies Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Natural Killer Cell Therapies Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapies Revenue in 2019
- 3.2.5 Global Natural Killer Cell Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Natural Killer Cell Therapies Price by Manufacturers
- 3.4 Natural Killer Cell Therapies Manufacturing Base Distribution, Product Types
- 3.4.1 Natural Killer Cell Therapies Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Natural Killer Cell Therapies Product Type
- 3.4.3 Date of International Manufacturers Enter into Natural Killer Cell Therapies Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Natural Killer Cell Therapies Market Size by Type (2015-2020)
- 4.1.1 Global Natural Killer Cell Therapies Sales by Type (2015-2020)
- 4.1.2 Global Natural Killer Cell Therapies Revenue by Type (2015-2020)
- 4.1.3 Natural Killer Cell Therapies Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Natural Killer Cell Therapies Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Natural Killer Cell Therapies Sales Forecast by Type (2021-2026)
- 4.2.2 Global Natural Killer Cell Therapies Revenue Forecast by Type (2021-2026)
- 4.2.3 Natural Killer Cell Therapies Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Natural Killer Cell Therapies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Natural Killer Cell Therapies Market Size by Application (2015-2020)
- 5.1.1 Global Natural Killer Cell Therapies Sales by Application (2015-2020)
- 5.1.2 Global Natural Killer Cell Therapies Revenue by Application (2015-2020)
- 5.1.3 Natural Killer Cell Therapies Price by Application (2015-2020)
- 5.2 Natural Killer Cell Therapies Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Natural Killer Cell Therapies Sales Forecast by Application (2021-2026)
- 5.2.2 Global Natural Killer Cell Therapies Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Natural Killer Cell Therapies Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Natural Killer Cell Therapies by Country
- 6.1.1 North America Natural Killer Cell Therapies Sales by Country
- 6.1.2 North America Natural Killer Cell Therapies Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Natural Killer Cell Therapies Market Facts & Figures by Type
- 6.3 North America Natural Killer Cell Therapies Market Facts & Figures by Application
7 Europe
- 7.1 Europe Natural Killer Cell Therapies by Country
- 7.1.1 Europe Natural Killer Cell Therapies Sales by Country
- 7.1.2 Europe Natural Killer Cell Therapies Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Natural Killer Cell Therapies Market Facts & Figures by Type
- 7.3 Europe Natural Killer Cell Therapies Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Natural Killer Cell Therapies by Region
- 8.1.1 Asia Pacific Natural Killer Cell Therapies Sales by Region
- 8.1.2 Asia Pacific Natural Killer Cell Therapies Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Natural Killer Cell Therapies Market Facts & Figures by Type
- 8.3 Asia Pacific Natural Killer Cell Therapies Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Natural Killer Cell Therapies by Country
- 9.1.1 Latin America Natural Killer Cell Therapies Sales by Country
- 9.1.2 Latin America Natural Killer Cell Therapies Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Natural Killer Cell Therapies Market Facts & Figures by Type
- 9.3 Central & South America Natural Killer Cell Therapies Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Natural Killer Cell Therapies by Country
- 10.1.1 Middle East and Africa Natural Killer Cell Therapies Sales by Country
- 10.1.2 Middle East and Africa Natural Killer Cell Therapies Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Natural Killer Cell Therapies Market Facts & Figures by Type
- 10.3 Middle East and Africa Natural Killer Cell Therapies Market Facts & Figures by Application
11 Company Profiles
- 11.1 Nektar Therapeutics
- 11.1.1 Nektar Therapeutics Corporation Information
- 11.1.2 Nektar Therapeutics Description, Business Overview and Total Revenue
- 11.1.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Nektar Therapeutics Natural Killer Cell Therapies Products Offered
- 11.1.5 Nektar Therapeutics Recent Development
- 11.2 Innate
- 11.2.1 Innate Corporation Information
- 11.2.2 Innate Description, Business Overview and Total Revenue
- 11.2.3 Innate Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Innate Natural Killer Cell Therapies Products Offered
- 11.2.5 Innate Recent Development
- 11.3 Affimed
- 11.3.1 Affimed Corporation Information
- 11.3.2 Affimed Description, Business Overview and Total Revenue
- 11.3.3 Affimed Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Affimed Natural Killer Cell Therapies Products Offered
- 11.3.5 Affimed Recent Development
- 11.4 Chipscreen Biosciences
- 11.4.1 Chipscreen Biosciences Corporation Information
- 11.4.2 Chipscreen Biosciences Description, Business Overview and Total Revenue
- 11.4.3 Chipscreen Biosciences Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Chipscreen Biosciences Natural Killer Cell Therapies Products Offered
- 11.4.5 Chipscreen Biosciences Recent Development
- 11.5 Fate Therapeutics
- 11.5.1 Fate Therapeutics Corporation Information
- 11.5.2 Fate Therapeutics Description, Business Overview and Total Revenue
- 11.5.3 Fate Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Fate Therapeutics Natural Killer Cell Therapies Products Offered
- 11.5.5 Fate Therapeutics Recent Development
- 11.6 Glycostem
- 11.6.1 Glycostem Corporation Information
- 11.6.2 Glycostem Description, Business Overview and Total Revenue
- 11.6.3 Glycostem Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Glycostem Natural Killer Cell Therapies Products Offered
- 11.6.5 Glycostem Recent Development
- 11.7 Dragonfly Therapeutics
- 11.7.1 Dragonfly Therapeutics Corporation Information
- 11.7.2 Dragonfly Therapeutics Description, Business Overview and Total Revenue
- 11.7.3 Dragonfly Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Dragonfly Therapeutics Natural Killer Cell Therapies Products Offered
- 11.7.5 Dragonfly Therapeutics Recent Development
- 11.8 Kiadis Pharma
- 11.8.1 Kiadis Pharma Corporation Information
- 11.8.2 Kiadis Pharma Description, Business Overview and Total Revenue
- 11.8.3 Kiadis Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Kiadis Pharma Natural Killer Cell Therapies Products Offered
- 11.8.5 Kiadis Pharma Recent Development
- 11.9 NantWorks
- 11.9.1 NantWorks Corporation Information
- 11.9.2 NantWorks Description, Business Overview and Total Revenue
- 11.9.3 NantWorks Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 NantWorks Natural Killer Cell Therapies Products Offered
- 11.9.5 NantWorks Recent Development
- 11.10 Nkarta Therapeutics
- 11.10.1 Nkarta Therapeutics Corporation Information
- 11.10.2 Nkarta Therapeutics Description, Business Overview and Total Revenue
- 11.10.3 Nkarta Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Nkarta Therapeutics Natural Killer Cell Therapies Products Offered
- 11.10.5 Nkarta Therapeutics Recent Development
- 11.1 Nektar Therapeutics
- 11.1.1 Nektar Therapeutics Corporation Information
- 11.1.2 Nektar Therapeutics Description, Business Overview and Total Revenue
- 11.1.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Nektar Therapeutics Natural Killer Cell Therapies Products Offered
- 11.1.5 Nektar Therapeutics Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Natural Killer Cell Therapies Market Estimates and Projections by Region
- 12.1.1 Global Natural Killer Cell Therapies Sales Forecast by Regions 2021-2026
- 12.1.2 Global Natural Killer Cell Therapies Revenue Forecast by Regions 2021-2026
- 12.2 North America Natural Killer Cell Therapies Market Size Forecast (2021-2026)
- 12.2.1 North America: Natural Killer Cell Therapies Sales Forecast (2021-2026)
- 12.2.2 North America: Natural Killer Cell Therapies Revenue Forecast (2021-2026)
- 12.2.3 North America: Natural Killer Cell Therapies Market Size Forecast by Country (2021-2026)
- 12.3 Europe Natural Killer Cell Therapies Market Size Forecast (2021-2026)
- 12.3.1 Europe: Natural Killer Cell Therapies Sales Forecast (2021-2026)
- 12.3.2 Europe: Natural Killer Cell Therapies Revenue Forecast (2021-2026)
- 12.3.3 Europe: Natural Killer Cell Therapies Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Natural Killer Cell Therapies Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Natural Killer Cell Therapies Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Natural Killer Cell Therapies Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Natural Killer Cell Therapies Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Natural Killer Cell Therapies Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Natural Killer Cell Therapies Sales Forecast (2021-2026)
- 12.5.2 Latin America: Natural Killer Cell Therapies Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Natural Killer Cell Therapies Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Natural Killer Cell Therapies Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Natural Killer Cell Therapies Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Natural Killer Cell Therapies Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Natural Killer Cell Therapies Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Natural Killer Cell Therapies Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Natural Killer Cell Therapies Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Natural Killer Cell Therapies. Industry analysis & Market Report on COVID-19 Impact on Global Natural Killer Cell Therapies is a syndicated market report, published as COVID-19 Impact on Global Natural Killer Cell Therapies Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Natural Killer Cell Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
